Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Audhuy

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Annales De Medecine Interne|January 1, 1988
[HLA antigens and anti-insulin alloantibodies in type 1 diabetics]J F Blickle, D Vetter, B Audhuy, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1982
[Auer bodies and Ph1 chromosome: chronic myeloid pseudoleukemia?]S Mayer, A Falkenrodt, A Albert, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
[Acute myeloblastic leukemias and myelodysplasias: treatment with low doses of aracytine]B Pignon, A M Blaise, A Boilletot, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Role of the CD34+ 38- cells in posttransplant hematopoietic recoveryP Hénon, H Sovalat, D Bourderont, et al.
Bulletin Du Cancer|January 1, 1991
Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot studyP Dufour, F Maloisel, J P Bergerat, et al.
American Journal of Clinical Oncology|January 1, 1988
Zoladex as primary therapy in advanced prostatic cancer. A French cooperative trialR Metz, M Namer, L Adenis, et al.
Cancer|April 1, 1994
Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remissionP Dufour, J P Bergerat, J C Barats, et al.
Pathologie-Biologie|October 1, 1990
[Malignant melanoma: hepatic intra-arterial chemotherapy]D Khayat, V Cour, C Aigner, et al.
British Journal of Haematology|November 25, 1998
Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantationP Hénon, H Sovalat, M Becker, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Annales De Medecine Interne|January 1, 1988
[HLA antigens and anti-insulin alloantibodies in type 1 diabetics]J F Blickle, D Vetter, B Audhuy, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1982
[Auer bodies and Ph1 chromosome: chronic myeloid pseudoleukemia?]S Mayer, A Falkenrodt, A Albert, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
[Acute myeloblastic leukemias and myelodysplasias: treatment with low doses of aracytine]B Pignon, A M Blaise, A Boilletot, et al.
Stem Cells (Dayton, Ohio)|September 30, 2000
Role of the CD34+ 38- cells in posttransplant hematopoietic recoveryP Hénon, H Sovalat, D Bourderont, et al.
Bulletin Du Cancer|January 1, 1991
Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot studyP Dufour, F Maloisel, J P Bergerat, et al.
American Journal of Clinical Oncology|January 1, 1988
Zoladex as primary therapy in advanced prostatic cancer. A French cooperative trialR Metz, M Namer, L Adenis, et al.
Cancer|April 1, 1994
Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remissionP Dufour, J P Bergerat, J C Barats, et al.
Pathologie-Biologie|October 1, 1990
[Malignant melanoma: hepatic intra-arterial chemotherapy]D Khayat, V Cour, C Aigner, et al.
British Journal of Haematology|November 25, 1998
Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantationP Hénon, H Sovalat, M Becker, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.
Pageof 5